2025-05-12 - Analysis Report
Okay, here's an analysis of Teva Pharmaceutical Industries Ltd ADR (TEVA), incorporating the provided data. The report is in English, with key numbers presented first followed by analysis.

**TEVA (Teva Pharmaceutical Industries Ltd ADR) Analysis**

Teva Pharmaceutical Industries Ltd. ADR is a global pharmaceutical company specializing in generic and specialty medicines.

**1. Performance vs. S&P 500 (VOO)**

*   **TEVA Cumulative Return:** 67.77%
*   **VOO Cumulative Return:** 87.98%
*   **Absolute Deviation (TEVA - VOO):** -20.2%
*   **Deviation Range (Max: 21.8%, Min: -132.2%):**
*   **Relative Deviation:** 72.7

**Analysis:**

TEVA has underperformed the S&P 500 (VOO) over the specified period. The absolute deviation is -20.2%, indicating a significant lag. The relative deviation of 72.7 suggests that TEVA's performance is in the upper range of its historical deviation from VOO, but still negative.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD   | Alpha   | Beta   | Cap(B)  |
| :----------- | :------- | :------ | :------ | :----- | :------ |
| 2015-2017  | -43.0%   | 58.5%  | -75.0%  | 0.1    | 21.8   |
| 2016-2018  | -41.0%   | 70.4%  | -62.0%  | -0.0   | 17.7   |
| 2017-2019  | -17.0%   | 70.4%  | -51.0%  | -0.3   | 11.3   |
| 2018-2020  | -1.0%    | 70.4%  | -31.0%  | -0.2   | 11.1   |
| 2019-2021  | -23.0%   | 58.4%  | -83.0%  | -0.2   | 9.2    |
| 2020-2022  | 26.0%    | 74.8%  | 18.0%   | -0.3   | 10.5   |
| 2021-2023  | 38.0%    | 74.8%  | 18.0%   | -1.0   | 12.0   |
| 2022-2024  | 123.0%   | 74.8%  | 102.0%  | -0.9   | 25.3   |
| 2023-2025  | 77.0%    | 76.0%  | 51.0%   | -0.1   | 20.8   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  Shows significant volatility. While recent periods (2022-2024, 2023-2025) show high growth, earlier periods show substantial losses.
*   **MDD (Maximum Drawdown):** Consistently high, indicating significant risk and price fluctuations.
*   **Alpha:**  Generally negative, indicating underperformance relative to the benchmark *except* for the recent periods (2020-2022, 2021-2023, 2022-2024, 2023-2025) when it is positive and even highly positive (e.g., 102.0% for 2022-2024).
*   **Beta:**  Mostly negative, suggesting TEVA has a negative correlation with the market (S&P 500). When the S&P 500 rises, TEVA tends to fall, and vice-versa.
*   **Cap(B):** Market capitalization in Billions.

**2. Recent Stock Price Movement**

*   **Current Price:** 18.06999969482422
*   **Last Market Data:** {'price': 16.93, 'previousClose': 18.07, 'change': -6.31}
*   **5-Day Moving Average:** 16.874
*   **20-Day Moving Average:** 14.8925
*   **60-Day Moving Average:** 15.5347

**Analysis:**

The stock price is currently above its 5-day, 20-day, and 60-day moving averages, which typically signals short-term bullish momentum. However, the last market data shows a significant negative change (-6.31%), indicating a recent pullback or correction. The closing price of 16.93 is below today's price of 18.06999969482422.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.3707 (Low Risk)
*   **RSI (Relative Strength Index):** 88.23532808735004
*   **PPO (Percentage Price Oscillator):** 2.8238
*   **Recent (20-day) Relative Deviation Change:** 13.3 (+)  (Short-term increase)
*   **Expected Return (%):** -35.1 (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** A low-risk rating suggests the stock is currently in a relatively stable phase.
*   **RSI:**  An RSI of 88.23 indicates that the stock is heavily overbought, which could signal a potential correction or pullback.
*   **PPO:** A positive PPO suggests short-term bullish momentum.
*   **Relative Deviation Change:** The positive change indicates a recent increase in performance relative to the S&P 500, but the absolute deviation from VOO is still negative as per the previous analysis.
*   **Expected Return:** The negative expected return suggests that, based on current analysis, TEVA is projected to underperform the S&P 500 over the long term if you invest right now.

The recent negative change in price from the 'Last Market Data' suggests an immediate downside risk that needs to be considered despite the bullish signals from moving averages.

**4. Recent News & Significant Events**

*   **2025-05-09:** Major business developments, regulatory changes, or market events.
*   **2025-05-12:** Analyst discussions on performance, industry trends, and global economic factors.
*   **2025-05-08:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-05-10:** Market experts highlight both risks and opportunities.

**Analysis:**

Recent news points to significant activity affecting TEVA, including potential regulatory changes, market events, and volatility. Investors should closely monitor news and company announcements.

**5. Recent Earnings Analysis**

| Date       | EPS   | Revenue  |
| :---------- | :----- | :-------- |
| 2025-05-07 | 0.19  | 3.89 B$ |
| 2024-11-06 | -0.39  | 4.33 B$ |
| 2024-07-31 | -0.75  | 4.16 B$ |
| 2024-05-08 | -0.12  | 3.82 B$ |
| 2025-05-07 | -0.12  | 3.82 B$ |

**Analysis:**

*   Earnings per share (EPS) has been volatile, with recent fluctuations between positive and negative values. The latest EPS figure of 0.19 is positive.
*   Revenue has also fluctuated, with a general trend of remaining around $3.8B - $4.3B per quarter.

**6. Financial Information**

Revenue and Profitability:

| Quarter      | Revenue  | Profit Margin |
| :----------- | :------- | :------------ |
| 2025-03-31   | $3.89B  | 48.24%       |
| 2024-12-31   | $4.23B  | 50.15%       |
| 2024-09-30   | $4.33B  | 49.60%       |
| 2024-06-30   | $4.16B  | 48.61%       |
| 2024-03-31   | $3.82B  | 46.37%       |

Capital and Profitability:

| Quarter      | Equity   | ROE        |
| :----------- | :-------- | :--------- |
| 2025-03-31   | $6.26B   | 3.42%      |
| 2024-12-31   | $5.37B   | -4.04%     |
| 2024-09-30   | $6.07B   | -7.21%     |
| 2024-06-30   | $6.36B   | -13.30%    |
| 2024-03-31   | $7.28B   | -1.91%     |

**Analysis:**

*   **Revenue:** Relatively stable over the past year.
*   **Profit Margin:** Relatively stable, fluctuating around 46-50%.
*   **Equity:** Fluctuating, with recent declines.
*   **ROE (Return on Equity):** Shows volatility, with recent periods showing improving but low returns. A ROE of 3.42% is not very attractive.

**7. Overall Analysis**

TEVA presents a mixed picture.

*   **Underperformance:** TEVA has underperformed the S&P 500 historically, and its expected long-term return is also negative relative to the index.
*   **Volatility:** The stock exhibits high volatility, as indicated by the high MDD and recent price fluctuations.
*   **Recent Momentum:** Recent data suggests a possible short-term bullish momentum, but with the RSI at overbought levels.
*   **News & Events:** Recent news highlights significant activity, suggesting a dynamic environment for the company.
*   **Financials:** Revenue and profit margins are relatively stable, but equity and ROE show volatility.

**Conclusion:**

TEVA appears to be a high-risk, high-reward investment. Recent momentum might attract short-term traders, but the long-term underperformance and negative expected return relative to the S&P 500 warrant caution. Investors should closely monitor news and financial reports and carefully consider their risk tolerance before investing in TEVA. A detailed risk and opportunity evaluation, considering regulatory landscape changes and market events, is highly recommended.
